Results 201 to 210 of about 373,948 (350)
Does pre-emptive dexamethasone provide prophylaxis against sugammadex-induced bradycardia? A retrospective study. [PDF]
Jahr JS+6 more
europepmc +1 more source
Effect of Addition of Dexamethasone to Local Anaesthetics in Supraclavicular Brachial Plexus Block
S. M. Rafiqul Islam+2 more
openalex +2 more sources
Dexamethasone and DMSO in experimental transorbital cerebral infarction. [PDF]
J. C. de la Torre, Jane W. Surgeon
openalex +1 more source
Objective To evaluate the applicability of the 2016 EULAR/ACR/PRINTO macrophage activation syndrome (MAS) classification criteria in patients with Still's disease (sJIA‐SD) treated with IL‐1‐targeted therapy and to assess the incidence of MAS in this context.
Remco G.A. Erkens+14 more
wiley +1 more source
The effect of adding dexamethasone to adductor block and IPACK block on acute postoperative, rebound, and chronic pain following knee arthroplasty-1-year follow-up. [PDF]
Sreckovic S+8 more
europepmc +1 more source
Effect of dexamethasone on experimental cerebral infarction in the gerbil [PDF]
Michael Harrison, R W Russell
openalex +1 more source
Abstract Obesity stands out as one of the most significant health problems in the modern world. The prevalence of high‐calorie diets (HCDs) globally exacerbates this condition. Throughout history, plants and plant‐derived food products have been utilized for medicinal purposes, demonstrating their efficacy in the treatment and prevention of various ...
Bedia Bati
wiley +1 more source
Drug-induced hypesthesia due to dexamethasone: A case report. [PDF]
Jia W, Yang B.
europepmc +1 more source
Isolation of rat hepatoma cell variants selectively resistant to dexamethasone inhibition of plasminogen activator [PDF]
Sarah Carlson Seifert, Thomas Gelehrter
openalex +1 more source
Aims This review aimed to synthesise the evidence related to the incidence of serious and non‐serious adverse events with the use of monoclonal antibodies (mAbs) among COVID‐19 patients. Methods Databases were searched from January 2020 to September 2023 for randomized clinical trials (RCTs) that used mAbs for the treatment of COVID‐19 regardless of ...
Htet Htet+6 more
wiley +1 more source